PSP Investments Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

One of the most striking characteristics of the PSP Investments portfolio is its sheer breadth. With 1,324 distinct holdings , the institution demonstrates a commitment to deep diversification. In the world of institutional finance, a portfolio containing more than 1,000 stocks typically indicates a multi-faceted investment strategy. It suggests that PSP Investments likely employs a "core-satellite" approach, where a significant portion of the capital is anchored in high-conviction, large-cap "ballast" stocks, while the remainder is distributed across a wide array of sectors and market caps to capture broader market returns and mitigate idiosyncratic risks. This level of diversification is a hallmark of large-scale pension funds, which must avoid excessive concentration that could lead to catastrophic volatility, given their long-term liability structures.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

Perhaps the most significant trend in this quarter's data is the strengthening of the Healthcare sector (8.72%) . In the context of a pension fund, an increase in healthcare exposure often signals a shift toward a more "defensive" posture. Healthcare companies typically offer more stable earnings and are less sensitive to economic downturns compared to pure-play technology or consumer discretionary firms. The massive new position in AstraZeneca, which we will discuss later, is a prime example of this rotation. By bolstering its healthcare holdings, PSP Investments is effectively building a "buffer" against potential volatility in the higher-beta tech sector.

Based on this sector layout, we can infer that PSP Investments is navigating a "late-cycle" or "transition-phase" economy. The heavy tech weight shows they are not willing to miss out on the AI-driven productivity boom, but the rising healthcare weight and the solid financial anchor suggest they are preparing for a potential slowdown or increased market turbulence. They are pursuing a "Barbell Strategy" : on one end, high-growth technology; on the other, defensive healthcare and stable, dividend-paying financials. This is a classic institutional response to an environment characterized by both technological disruption and macroeconomic fragility.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

NVIDIA remains the crown jewel of the PSP Investments portfolio, holding the number one spot with a market value of $1.61 billion. This is a "conviction holding" in every sense of the word. Despite a slight decrease in portfolio weight (from 5.61% to 5.02%), the institution actually added 3.11% more shares during the quarter. This discrepancy—adding shares while the weight decreases—is a critical data point. It suggests that while PSP continues to believe in NVIDIA's fundamental story, the stock's price performance during this specific window may have lagged the broader portfolio's growth, or more likely, the institution is "trimming into strength" to prevent the position from becoming an oversized risk. NVIDIA’s dominance in the data center and AI accelerator market is the primary driver here. By holding over 9.2 million shares, PSP is ensuring it remains at the forefront of the generative AI revolution. The motivation is clear: NVIDIA is the "toll booth" for the AI era, and as long as capital expenditure in cloud computing remains high, NVIDIA is the primary beneficiary.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The most significant move this quarter was the initiation of a massive new position in AstraZeneca, valued at over $415 million . This is not just a "new position"; it is an immediate entry into the upper echelon of the portfolio (Rank 11). The motivation here is clearly a "growth acceleration bet" within a defensive sector. AstraZeneca has one of the strongest oncology pipelines in the pharmaceutical industry, and its diversification across respiratory, immunology, and rare diseases provides a robust earnings profile. For a pension fund, AZN offers the perfect blend: the stability of a global healthcare giant and the growth potential of cutting-edge biotechnology. This move signals that PSP Investments is looking for "non-correlated growth"—assets that can perform well even if the broader tech-driven market takes a breather. It is a strategic entry into a "safe haven" with a high-growth engine.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The reduction of nearly 40% of the position in Bank of America is the most significant "rebalancing" move in the financial sector. With an estimated $93 million realized, this is a "Major Strategic Contraction." The logic here is likely twofold. First, after a period of strong performance, PSP may be taking profits to reallocate into the Canadian banking sector (RY, BMO), which they perceive as having a better risk-reward profile or more stable dividend prospects. Second, it may reflect a cautious view on the US consumer and the potential for increased credit costs in the US banking system. By trimming BAC, PSP is reducing its exposure to the volatility of the US financial cycle.

The reductions in Parker-Hannifin (-25.16%) and Analog Devices (-18.48%) point to a "Tactical Defense" against cyclicality. Parker-Hannifin is a bellwether for global industrials, and Analog Devices is a key player in the "analog" semiconductor space (auto, industrial). By trimming these names, PSP is signaling a belief that the industrial cycle may be peaking or that these sectors will face headwinds in a high-interest-rate environment. This capital is being recycled into the "AI Infrastructure" names like Eaton, which have a more specific and powerful growth catalyst.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

While the headlines often focus on software and chips, PSP’s maneuvers this quarter reveal a much deeper logic. The institution is looking at the "secondary and tertiary effects" of the technological revolution. By aggressively adding to Eaton Corporation and Constellation Energy , they are acknowledging that the digital world cannot exist without a massive expansion of the physical power grid. This is a "picks and shovels" play for the 21st century.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.